Summary
Both peptides fall into a similar broad context as Hormone peptides, although the details of how they are used and discussed still diverge. Their typical research and application settings separate fairly clearly: Ipamorelin is more often discussed in the realm of Metabolic and endocrine and Musculoskeletal health, whereas Melanotan I is more often associated with the realm of Dermatology and aesthetics. Both appear to work through Receptor agonist, but the functional emphasis still separates, with Ipamorelin leaning toward Anabolic growth and Lipolysis and fat loss and Melanotan I leaning toward Melanogenesis modulation. Ipamorelin has a more synthetic design origin, while Melanotan I is closer to synthetic analog background with Ipamorelin in Preclinical development and Melanotan I approved for Research use only. They are also usually discussed through the same administration routes, namely subcutaneous injection.